Skip to content

Clinical trials

Lung Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Belgium Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20082
20091
20101
20111
20132
20144
20154
20162
20173
20182
20196
20204
20223
20232
20244
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting11
Active, not recruiting3
Terminated3
Withdrawn2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Pfizer5
Novartis Pharmaceuticals3
Cliniques universitaires Saint-Luc- Université Catholique de Louvain2
Eli Lilly and Company2
Hoffmann-La Roche2
United Therapeutics2
University Hospital, Antwerp2
Bayer1
Centre Hospitalier Universitaire de Tivoli1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases47
Respiratory Tract Diseases21
Lung Neoplasms11
Carcinoma, Non-Small-Cell Lung9
Neoplasms8
Asthma7
Pulmonary Disease, Chronic Obstructive7
Thoracic Neoplasms7
Lung Diseases, Obstructive6
Respiratory Tract Neoplasms6

Trials

Showing 51 to 47 of 47. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.